Alcon Inc. logo

Alcon Inc.

ALC.SW
HealthcareSIXSwitzerland
58.50CHF+0.18 (+0.31%)

About Alcon

Alcon Inc. is a global eye care company that researches, develops, manufactures, and markets products for eye care professionals and their patients.

It operates through two segments:

  • Surgical:
    Offers equipment, diagnostics, instrumentation, intraocular lenses (IOLs), and consumables for surgical procedures.
    Key products include:

    • Cataract Surgery: Centurion Vision System, LenSx femtosecond laser, LuxOR microscope, NGENUITY 3D visualization, ORA intra-op system, Custom Pak procedure packs.

    • Vitreoretinal Surgery: Constellation Vision System, lasers, hand-held instruments, MIVS, Grieshaber tools, vitrectomy probes (e.g., Hypervit), and tamponades.

    • Refractive Surgery: WaveLight lasers, Contoura Vision (used in LASIK).

    • Glaucoma: EX-PRESS filtration device.

    • Implantables: AcrySof IQ IOLs (monofocal and advanced technology lenses like PanOptix and ReSTOR for presbyopia and astigmatism correction).

  • Vision Care:
    Provides contact lenses and a wide range of ocular health products.

    • Contact Lenses: TOTAL, PRECISION, DAILIES AquaComfort PLUS, and Air Optix (daily disposable, reusable, and color-enhancing).

    • Ocular Health: Opti-Free, Clear Care (contact lens solutions), Tears Naturale, Genteal (dry eye), ICAPS, Vitalux (vitamins), and treatments for glaucoma and allergies.

Founded in 1945, Alcon is headquartered in Geneva, Switzerland.

Alcon's Business Strategy

Alcon operates as a pure-play eye care company following its 2019 spin-off from Novartis, focusing exclusively on surgical equipment, implantables, and vision care products. This specialized approach has positioned Alcon as the global leader in ophthalmology, with comprehensive offerings spanning the full spectrum of eye…

Available on Finplify

Free account required

Sign up free

Our Take on Alcon

Pros:

Favorable Megatrends: With global aging and rising rates of myopia, dry eye, and cataracts, Alcon benefits from structural, non-cyclical demand for both surgical and vision care products: particularly in developed markets and emerging Asia.

Eye Care Innovation: Alcon has a strong track record…

Available on Finplify

Free account required

Sign up free

Company Details

Exchange
SIX
Country
Switzerland
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
David J. Endicott
Employees
25,599
IPO Date
2019-04-08
ISIN
CH0432492467
Website
alcon.com

Key Metrics

Market Cap
28.51BCHF
P/E Ratio (TTM)
37.02
Net Profit Margin
9.42%
Debt / Asset Ratio
0.17
Dividend Yield (TTM)
0.45%
Volume
295,911
Avg Volume
1.09M
Shares Outstanding
487.43M
Free Float
99.76%
β Beta
0.70
52W Range
57.7 - 85.2

Fundamental Analysis

Proprietary 5-category scoring system

Score Fingerprint

Section Scores

Profitability
2.5/5Weak
Liquidity
3.9/5Good
Leverage
5.0/5Excellent
Cash Flow
4.5/5Excellent
Valuation
3.1/5Average

Full Breakdown & Peer Ranking

See the detailed score for every metric and how this stock ranks against its sector peers

Unlock for free
Free to join

Unlock the full research on Alcon

Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.

300+ Curated Stocks

A hand-picked universe of world-class businesses across every major market and sector.

AI Analyst Briefings

Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.

Proprietary Fundamentals

Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.